Opinion
- Author:
- Eric J. Topol, MD
Publish date: February 21, 2024
“It’s astounding how devious cancer cells and tumor tissue can be.”
Opinion
- Author:
- Eric J. Topol, MD
Publish date: December 14, 2022
Semaglutide and other drugs for weight loss were being developed for improving glucose regulation and unexpectedly were found to achieve significan...
Opinion
- Author:
- Eric J. Topol, MD
Publish date: November 14, 2022
For older patients, we should be thinking of why we should be using Paxlovid rather than the reason not to treat.
Article
- Author:
- Eric J. Topol, MD
Publish date: December 1, 2004
The withdrawal of rofecoxib (Vioxx) has important implications both for patients with arthritis and for the pharmaceutical field in general.
Article
- Author:
- Eric J. Topol, MD
Publish date: July 1, 2003
CRP is now a recognized cardiac test. But who should be tested?
Article
- Author:
- Eric J. Topol, MD
Publish date: January 1, 2003
One should suspect thyrotoxicosis in patients with palpitations, tachycardia, exercise intolerance, or dyspnea on exertion.
Article
- Author:
- Eric J. Topol, MD
Publish date: April 1, 2002
Article
- Author:
- Eric J. Topol, MD
Publish date: November 1, 2001
Our study had limitations, but we believe our hypothesis is plausible, our methods were valid, and our conclusions are sound.
Article
- Author:
- Eric J. Topol, MD
Publish date: June 1, 2001
Elevated levels of CRP are associated with increased cardiovascular risk.
Article
- Author:
- Eric J. Topol, MD
Publish date: October 1, 1999
Acute coronary syndromes occur when vulnerable plaque ruptures, leading to acute thrombosis. With an illustration explaining this chain of events.<...
Article
- Author:
- Eric J. Topol, MD
Publish date: January 1, 1997
The optimal thrombolytic therapy will be a cocktail of several thrombolytic, antithrombotic, and antiplatelet agents, each of which attacks differe...
